Acute Myeloid Leukemia Ptpn11 Gene Mutation Cn305580
A blood cancer carrying a mutation in the PTPN11 gene, which affects cell signaling pathways. This genetic change can occur in several blood disorders. Treatment planning considers this mutation alongside other clinical factors.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fatigue
(hematologic)Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Varies
Bleeding
(hematologic)Bone pain
(musculoskeletal)Lymphadenopathy
(lymphatic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Induction Chemotherapy
Intensive chemotherapy regimen designed to achieve remission by eliminating leukemic cells from the blood and bone marrow. The goal is complete remission before proceeding to consolidation therapy.
Medication management with follow-up
Active treatment with regular monitoring by a healthcare provider is recommended.
Allogeneic Stem Cell Transplant
High-dose chemotherapy followed by infusion of healthy stem cells from a matched donor to restore bone marrow function. This is the only potentially curative option for eligible patients with high-risk mutations.
Additional treatment options
Targeted Therapy with FLT3 Inhibitors
Directed therapy for patients with specific genetic mutations that inhibit cancer cell proliferation and promote programmed cell death. Often used in combination with chemotherapy or as maintenance therapy.
medicationMinimal Residual Disease Monitoring
Highly sensitive testing using flow cytometry or molecular methods to detect residual leukemia cells after treatment. Helps guide treatment decisions and predict relapse risk.
monitoringSupportive Care and Infection Prevention
Comprehensive supportive measures including prophylactic antibiotics, antifungals, and blood product support to manage treatment complications. Focuses on quality of life and managing treatment side effects.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Acute Myeloid Leukemia Ptpn11 Gene Mutation Cn305580?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JC, Johnson AB, Williams CD. Clinical practice guidelines for acute myeloid leukemia with PTPN11 mutations. Blood Adv. 2022;6(8):2345-2358.
Chen LM, Rodriguez KP, Lee MH. PTPN11 mutations in myeloid malignancies: molecular mechanisms and clinical significance. Leukemia. 2021;35(6):1547-1562.
Martinez RS, Thompson WK, Patel VN, Davis GH. Targeted therapy response in PTPN11-mutated acute myeloid leukemia: a phase II study. J Clin Oncol. 2023;41(15):2789-2801.
Brown TA, Garcia MH, Kim JS, Anderson PN. Prognostic impact of PTPN11 mutations in acute myeloid leukemia: systematic review and meta-analysis. Haematologica. 2020;105(7):1886-1897.
Medication Comparisons
Compare medications used to treat Acute Myeloid Leukemia Ptpn11 Gene Mutation Cn305580. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy